Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Radiomic Signature Of 18F Fluorodeoxyglucose PET/CT For Prediction Of Gastric Cancer Survival And Chemotherapeutic Benefits
Y. Jiang, Qingyu Yuan, Wenbing Lv, S. Xi, W. Huang, Z. Sun, Hao Chen, Liying Zhao, W. Liu, Y. Hu, L. Lu, J. Ma, T. Li, Jiang Yu, Q. Wang, G. Li
Published 2018 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
We aimed to evaluate whether radiomic feature-based fluorine 18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging signatures allow prediction of gastric cancer (GC) survival and chemotherapy benefits. Methods: A total of 214 GC patients (training (n = 132) or validation (n = 82) cohort) were subjected to radiomic feature extraction (80 features). Radiomic features of patients in the training cohort were subjected to a LASSO cox analysis to predict disease-free survival (DFS) and overall survival (OS) and were validated in the validation cohort. A radiomics nomogram with the radiomic signature incorporated was constructed to demonstrate the incremental value of the radiomic signature to the TNM staging system for individualized survival estimation, which was then assessed with respect to calibration, discrimination, and clinical usefulness. The performance was assessed with concordance index (C-index) and integrated Brier scores. Results: Significant differences were found between the high- and low-radiomic score (Rad-score) patients in 5-year DFS and OS in training and validation cohorts. Multivariate analysis revealed that the Rad-score was an independent prognostic factor. Incorporating the Rad-score into the radiomics-based nomogram resulted in better performance (C-index: DFS, 0.800; OS, 0.786; in the training cohort) than TNM staging system and clinicopathologic nomogram. Further analysis revealed that patients with higher Rad-scores were prone to benefit from chemotherapy. Conclusion: The newly developed radiomic signature was a powerful predictor of OS and DFS. Moreover, the radiomic signature could predict which patients could benefit from chemotherapy.
This paper references
Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer
Y. Jiang (2018)
-2-deoxyglucose PET, prognosis, and epithelial-mesenchymal transition in non-small cell lung cancer
Concordance probability and discriminatory power in proportional hazards regression
M. Gonen (2005)
Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study
D. Lee (2015)
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
H. Zhang (2013)
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
J. Zhang (2013)
Evaluating Random Forests for Survival Analysis using Prediction Error Curves.
U. Mogensen (2012)
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
P. Yushkevich (2006)
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
S. Noh (2014)
Prognostic and Predictive Value of p21-activated Kinase 6 Associated Support Vector Machine Classifier in Gastric Cancer Treated by 5-fluorouracil/Oxaliplatin Chemotherapy
Y. Jiang (2017)
ImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer
Y. Jiang (2018)
R. Camp (2004)
Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
K. Ozturk (2018)
Corrigendum: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
R. Sun (2018)
A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma
Sudeep Banerjee (2015)
Evolving role of FDG-PET/CT in prognostic evaluation of resectable gastric cancer
E. De Raffele (2017)
The 18F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes
Jinhyun Choi (2018)
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers
A. J. Vickers (2008)
Robustness of Radiomic Features in [11C]Choline and [18F]FDG PET/CT Imaging of Nasopharyngeal Carcinoma: Impact of Segmentation and Discretization
L. Lu (2016)
Regression shrinkage and selection via the lasso: a retrospective
R. Tibshirani (2011)
Efron-type measures of prediction error for survival analysis.
T. Gerds (2007)
Genetics of gastric cancer.
N. Peddanna (1995)
SU-E-J-258: Prediction of Cervical Cancer Treatment Response Using Radiomics Features Based On F18-FDG Uptake in PET Images
B. Altazi (2015)
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer
S. Liao (2011)
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
R. Leijenaar (2015)
Molecular classification of gastric cancer
C. Röcken (2017)
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.
X. Paoletti (2010)
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery
M. Kirienko (2017)
Interleukin-17–Producing Neutrophils Link Inflammatory Stimuli to Disease Progression by Promoting Angiogenesis in Gastric Cancer
Tuan-Jie Li (2016)
Imaging biomarker roadmap for cancer studies
J. O’Connor (2017)
Global cancer statistics, 2012
L. Torre (2015)
Relationship between F-18-FDG PET/CT findings and HER2 expression in gastric cancer
RH Chen (2016)
Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment
Sung Hyun Yoon (2016)
Statistical methods for conducting agreement (comparison of clinical tests) and precision (repeatability or reproducibility) studies in optometry and ophthalmology
C. Mcalinden (2011)
Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent.
Noah Simon (2011)
Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer
Y. Jiang (2017)
Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.
Chang-Qi Zhu (2010)
How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy
D. Mankoff (2015)
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer
B. Song (2015)
Radiomics and radiogenomics in lung cancer: A review for the clinician.
R. Thawani (2018)
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set
H. Li (2016)
Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass‐Forming Cholangiocarcinoma From Hepatocellular Carcinoma
Xianlun Zou (2019)
Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response
P. Kickingereder (2016)
Prognostic value of metabolic parameters on preoperative 18F-Fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III gastric cancer
Sae Jung Na (2016)
Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker
F. Giganti (2016)
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
K. Pinker (2016)
Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis
Zhonghua Wu (2017)
Regression modelling strategies for improved prognostic prediction.
F. Harrell (1984)
Genetics: New molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas
M. Razzak (2014)
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
T. Coroller (2015)
Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
J. Cheong (2018)
Metabolic Signature on 18F-FDG PET/CT, HER2 Status, and Survival in Gastric Adenocarcinomas
R. Celli (2016)
Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer
Ruohua Chen (2016)
Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis.
Su Yeon Ahn (2016)
Radiogenomic analysis demonstrates associations between
Radiomics: the process and the challenges.
Virendra Kumar (2012)
Radiomics: extracting more information from medical images using advanced feature analysis.
P. Lambin (2012)
Role of 18F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection
J. Lee (2012)
Regularization Paths for Generalized Linear Models via Coordinate Descent.
J. Friedman (2010)
Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
S. Yamamoto (2016)
Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit
Y. Jiang (2018)
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Yanqi Huang (2016)
Global cancer statistics
D. Parkin (1999)
This paper is referenced by
Young age increases risk for lymph node positivity in gastric cancer: A Chinese multi-institutional database and US SEER database study
Yuming Jiang (2020)
A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors
X. Xu (2019)
Artificial intelligence in gastrointestinal cancer: Recent advances and future perspectives
Michihiro Kudou (2020)
Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment 18F-PET/CT
Zheran Liu (2020)
Application of radiomics and machine learning in head and neck cancers
Zhouying Peng (2020)
Big Imaging Data: Klinische Bildanalyse mit Radiomics und Deep Learning
Aydin Demircioglu (2019)
Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy
Shin Hye Yoo (2021)
Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer
J. Fang (2020)
Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer
Yuming Jiang (2019)
A validated survival nomogram for early-onset diffuse gastric cancer
Fei Liao (2020)
Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer
Junmeng Li (2020)
Big Data Analytics and Radiomics to Discover Diagnostics and Therapeutics for Gastric Cancer
Kummetha Jagadish (2020)
Radiomics Signature on Computed Tomography Imaging: Association With Lymph Node Metastasis in Patients With Gastric Cancer
Y. Jiang (2019)
Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers
G. P. Nagaraju (2020)
Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
S. Wang (2020)
Radiomics Features of 18F-fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer
J. Kang (2019)
Radiomics approaches in gastric cancer: a frontier in clinical decision making
Yue Wang (2019)
Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer
X. Tang (2020)
Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
Y. Chen (2020)
CT radiomics and PET radiomics: ready for clinical implementation?
M. Bogowicz (2019)
Predicting Chemotherapeutic Response for Far-advanced Gastric Cancer by Radiomics with Deep Learning Semi-automatic Segmentation
J. Tan (2020)
Radiomics Analysis of Computed Tomography helps predict poor prognostic outcome in COVID-19
Qingxia Wu (2020)
Gastric cancer and image-derived quantitative parameters: Part 2—a critical review of DCE-MRI and 18F-FDG PET/CT findings
Lei Tang (2019)
Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review
Anne-Leen Deleu (2020)
Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
Zhenyu Liu (2020)
Introduction to Radiomics
M. Mayerhoefer (2020)
Identification of hsa_circ_0005654 as a new early biomarker of gastric cancer.
Yezhao Wang (2019)
Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study
Huanjun Wang (2020)
Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer
W. Huang (2020)